BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article

VANCOUVER, British Columbia, March 29, 2023 -- BetterLife Pharma Inc. , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental... | March 29, 2023

Related Keywords

United Kingdom ,United States ,Canada ,Vancouver ,British Columbia ,British ,David Melles ,Ahmad Doroudian ,Betterlife Pharma ,Johnd Mccorvy Medical College Of Wisconsin ,Drug Discovery Development ,Drug Discovery Development On ,Argel Aguilar Valles Carleton University ,Betterlife Pharma Inc ,Qlife Pharma ,Drug Discovery ,California San Diego ,Argel Aguilar Valles ,Carleton University ,Medical College ,Investor Relations ,Betterlife Pharma Inc Stock Exchange ,News ,Information ,Press Release ,Arch ,023 ,Betterlife ,Dharma ,N ,Merging ,Biotech ,Company ,Ocused ,The ,Development ,End ,Ommercialization ,F ,Treatments ,Or Betrf Ca08772p2026 ,